MOBIA MEDICAL INC
MOBINASDAQTrading Snapshot
- Day Range
- $11.94 – $12.21
- 52-Week Range
- $10.19 – $15.29
- Volume
- $1.78B
- Avg Volume
- $2.05B
- Shares Outstanding
- 33.3M
- Next Earnings
- Sep 17, 2026
Fundamentals Snapshot
- Annual Revenue
- $32M
- Last Q Revenue
- $12M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own MOBI
- ✓High-growth profile — revenue up +50.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 31% gross margin and 10% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About MOBIA MEDICAL INC
Mobia Medical, Inc. functions as a commercial-level medical device enterprise, concentrating on developing therapeutic solutions for individuals recovering from strokes who experience motor impairments. The company was established on March 5, 2007, by its founders Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, and it maintains its corporate headquarters in Austin, Texas.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Mobia Medical Q2 Earnings Call Highlights
Mobia Medical (NASDAQ:MOBI) reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs. The company, which completed its initial public offering
Mobia Medical Reports Second Quarter 2026 Financial Results
AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 and Recent Highlights Reported revenue of $13.5 million, representing 102% growth over the prior year periodAchieved gross margin of 83.2%Announced publication of two-year VNS-REHAB follow up data in Neurology®, de
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call Transcript
Mobia Medical, Inc. (MOBI) Q2 2026 Earnings Call August 11, 2026 4:30 PM EDTCompany ParticipantsRichard Foust - CEO, President & DirectorNelson Curnes -...
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directors
AUSTIN, Texas, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Myriam Curet, M.D., to the Board as an independent director, effective July 30, 2026. “We are thrilled Myriam will be joining the Mobia Medical Board of Directors,” said Richard Foust, President and Chief Executive Officer of Mobia Medical. “Her decade
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report second quarter 2026 financial results on Tuesday, August 11, 2026. Mobia Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Conference Call an
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced the appointment of Reza Zadno, Ph.D., to the Board as an independent director, effective July 14, 2026. Dr. Zadno will also serve as a member of the Compensation Committee. “We are pleased to welcome Reza to the Mobia Medical Board of Directors,” said Richard Foust, Pres